Actinium director granted 18K RSUs, 27K options
A director of Actinium Pharmaceuticals received new restricted stock units and stock options that vest over time under a Rule 10b5-1 trading plan.
Rhea-AI Filing Summary
Actinium Pharmaceuticals, Inc. (symbol: ATNM) is the issuer of record for a Form 4 filing submitted to the SEC. Almenoff June Sherie reported acquisition or exercise transactions in this Form 4 filing.
Actinium Pharmaceuticals, Inc. (ATNM) reported that director June Sherie Almenoff received equity awards on September 2, 2026 under a Rule 10b5-1 trading plan. She was granted 18,000 shares of common stock in the form of restricted stock units and 27,000 stock options to buy common shares at $1.00 per share.
The restricted stock units vest in three equal annual installments over three years, and the options vest in fifty equal monthly installments beginning on the grant date and expire on September 2, 2036. Following these awards, she directly holds 18,000 common shares and 27,000 options related to these grants.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Grant/Award: 45,000 shares
Grant/Award
2 txns
Insider
Almenoff June Sherie
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2 | 27,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 18,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 27,000 contracts (Direct);
Common Stock — 18,000 shares (Direct)
Footnotes (2)
- F1. Represents a grant of restricted stock units ("RSUs"). The RSUs vest as follows: 1/3 on the first anniversary of the date of grant, 1/3 on the second anniversary of the date of grant and 1/3 on the third anniversary of the date of grant.
- F2. The stock options vest and become exercisable in fifty equal monthly tranches beginning on the date of grant.
Key Figures
Restricted stock units granted: 18,000 shares
Stock options granted: 27,000 options
Option exercise price: $1.00 per share
+3 more
6 metrics
Restricted stock units granted
18,000 shares
Equity award to a director on September 2, 2026
Stock options granted
27,000 options
Equity award to a director on September 2, 2026
Option exercise price
$1.00 per share
Exercise price for the 27,000 stock options granted
Option expiration date
September 2, 2036
Expiration of the granted stock options
Common shares held after award
18,000 shares
Director’s direct common stock position from the RSU grant
Options held after award
27,000 options
Director’s options position related to this grant
Key Terms
restricted stock units ("RSUs"), stock options, Rule 10b5-1 trading plan
3 terms
restricted stock units ("RSUs") financial
"Represents a grant of restricted stock units ("RSUs")."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
stock options financial
"The stock options vest and become exercisable in fifty equal monthly tranches"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
Rule 10b5-1 trading plan regulatory
"transactions were made under a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
FAQ
What insider equity awards were reported at Actinium Pharmaceuticals (ATNM)?
A director received 18,000 restricted stock units and 27,000 stock options on September 2, 2026, each relating to Actinium Pharmaceuticals common stock, as part of her director compensation.
How do the 18,000 RSUs granted at ATNM vest?
The 18,000 RSUs vest in three equal parts: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary, and 1/3 on the third anniversary.
What are the key terms of the 27,000 stock options granted at ATNM?
The director received 27,000 stock options with an exercise price of $1.00 per share. They vest and become exercisable in fifty equal monthly tranches starting on the grant date and expire on September 2, 2036.
What are the director’s ATNM holdings after these reported awards?
After these awards, the director directly holds 18,000 shares of common stock from the restricted stock units and 27,000 stock options tied to Actinium Pharmaceuticals common shares reported in this filing.
Were the ATNM insider awards made under a Rule 10b5-1 trading plan?
Yes. The filing indicates the transactions were made under a Rule 10b5-1 trading plan, meaning the awards were granted pursuant to a pre-arranged plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
